Association between P2X7 receptor polymorphisms and bone status in mice

Journal of Osteoporosis

Volumn 2012, Issue , 2012, Pages

  Syberg, Susanne ^a,b   Schwarz, Peter ^a,b   Petersen, Solveig ^a,b   Steinberg, Thomas H ^c   Jensen, Jens Erik Beck ^b   Teilmann, Jenni ^b   Jorgensen, Niklas Rye ^a,b  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALKALINE PHOSPHATASE BONE ISOENZYME; CARBOXY TERMINAL TELOPEPTIDE; OSTEOCALCIN; PURINERGIC P2X7 RECEPTOR;

ALLELE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BONE MINERAL; BONE STRENGTH; CELL CULTURE; CHANNEL GATING; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; IN VITRO STUDY; INBRED STRAIN; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; P2X7 GENE; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 84876509180     PISSN: 20908059     EISSN: 20420064     Source Type: Journal    
DOI: 10.1155/2012/637986     Document Type: Article

References (44)

1. Dixon S. J., Sims S. M., P2 purinergic receptors on osteoblasts and osteoclasts: potential targets for drug development. Drug Development Research 2000 49 3 187 200 2-s2.0-0034081759 10.1002/(SICI)1098-2299(200003)49:3187::AID- DDR9>3.0.CO;2-F (Pubitemid 30324635)
2. 7 receptors in bone. Purinergic Signalling 2009 5 2 205 221 2-s2.0-67349186489 10.1007/s11302-009- 9139-1
3. 7 nucleotide receptor reveals its regulatory roles in bone formation and resorption. Molecular Endocrinology 2003 17 7 1356 1367 2-s2.0-0037634326 10.1210/me.2003-0021 (Pubitemid 36819956)
4. 7 nucleotide receptor mediates skeletal mechanotransduction. Journal of Biological Chemistry 2005 280 52 42952 42959 2-s2.0-30044443068 10.1074/jbc.M506415200 (Pubitemid 43049258)
5. Gartland A., Buckley K. A., Hipskind R. A., Perry M. J., Tobias J. H., Buell G., Chessell I., Bowler W. B., Gallagher J. A., Multinucleated osteoclast formation in vivo and in vitro by P2X 7 receptor-deficient mice. Critical Reviews in Eukaryotic Gene Expression 2003 13 2-4 243 253 2-s2.0-0346245902 10.1615/CritRevEukaryotGeneExpr.v13.i24.150 (Pubitemid 38009173)
6. Bowler W. B., Buckley K. A., Gartland A., Hipskind R. A., Bilbe G., Gallagher J. A., Extracellular nucleotide signaling: a mechanism for integrating local and systemic responses in the activation of bone remodeling. Bone 2001 28 5 507 512 2-s2.0-0035046976 10.1016/S8756-3282(01)00430-6 (Pubitemid 32410002)
7. North R. A., Molecular physiology of P2X receptors. Physiological Reviews 2002 82 4 1013 1067 2-s2.0-0036788971
8. 2+ Entry in Rabbit Osteoclasts. Journal of Biological Chemistry 2001 276 42 39107 39114 2-s2.0-0035914306 10.1074/jbc.M105881200
9. 7). Science 1996 272 5262 735 738 2-s2.0-0029665112
10. Ferrari D., Chiozzi P., Falzoni S., Dal Susino M., Melchiorri L., Baricordi O. R., Di Virgilio F., Extracellular ATP triggers IL-1 β release by activating the purinergic P2Z receptor of human macrophages. Journal of Immunology 1997 159 3 1451 1458 2-s2.0-0031201476 (Pubitemid 127484125)
11. Ferrari D., Los M., Bauer M. K. A., Vandenabeele P., Wesselborg S., Schulze-Osthoff K., P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. FEBS Letters 1999 447 1 71 75 2-s2.0-0033051323 10.1016/S0014-5793(99)00270-7 (Pubitemid 29134951)
12. 7 receptor. Journal of Biological Chemistry 2001 276 14 11135 11142 2-s2.0-0035815630 10.1074/jbc.M010353200 (Pubitemid 38089296)
13. 7 gene are associated to fracture risk and to effect of estrogen treatment. Pharmacogenetics and Genomics 2007 17 7 555 567 2-s2.0-34250210564 10.1097/FPC.0b013e3280951625 (Pubitemid 46905222)
14. 7 receptors. Journal of Biological Chemistry 2002 277 9 7574 7580 2-s2.0-0036510537 10.1074/jbc.M104608200 (Pubitemid 34953156)
15. 7 receptor-deficient mice. Critical Reviews in Eukaryotic Gene Expression 2003 13 2-4 243 253 2-s2.0-0346245902 10.1615/CritRevEukaryotGeneExpr.v13.i24.150 (Pubitemid 38009173)
16. 7 nucleotide receptor results in trafficking defects and impaired function. Journal of Immunology 2003 171 3 1304 1311 2-s2.0-0041845127 (Pubitemid 36900061)
17. 7 and inhibits osteoclast formation in RAW cells. American Journal of Physiology, Cell Physiology 2004 287 2 C403 C412 2-s2.0-3242702380 10.1152/ajpcell.00361.2003 (Pubitemid 38955231)
18. Hoebertz A., Arnett T. R., Burnstock G., Regulation of bone resorption and formation by purines and pyrimidines. Trends in Pharmacological Sciences 2003 24 6 290 297 2-s2.0-0038341740 10.1016/S0165-6147(03)00123-8 (Pubitemid 36725004)
19. Morrison M. S., Turin L., King B. F., Burnstock G., Arnett T. R., ATP is a potent stimulator of the activation and formation of rodent osteoclasts. Journal of Physiology 1998 511 2 495 500 2-s2.0-0003982630 10.1111/j.1469-7793. 1998.495bh.x (Pubitemid 28444617)
20. 7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesis. Journal of Cell Biology 2008 181 5 859 871 2-s2.0-44649092795 10.1083/jcb.200708037 (Pubitemid 351786989)
21. 7 nucleotide receptors mediate blebbing in osteoblasts through a pathway involving lysophosphatidic acid. Journal of Biological Chemistry 2007 282 5 3403 3412 2-s2.0-34047243995 10.1074/jbc.M605620200 (Pubitemid 47084361)
22. 7 receptor impairs ATP-induced IL-1 β release from human monocytes. Journal of Immunology 2004 172 6 3399 3405 2-s2.0-1542619335 (Pubitemid 38337918)
23. 7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 2005 114 3 386 396 2-s2.0-20144375454 10.1016/j.pain.2005.01.002 (Pubitemid 40385877)
24. 7 receptor. Journal of Immunology 2002 169 8 4108 4112 2-s2.0-0037108511 (Pubitemid 35178179)
25. 7 receptor impairs cell death but not phospholipase D activation in murine thymocytes. Journal of Biological Chemistry 2004 279 17 16918 16926 2-s2.0-2342423633 10.1074/jbc.M313064200 (Pubitemid 38560444)
26. 7 receptors. Journal of Biological Chemistry 2001 276 1 125 132 2-s2.0-0035808396 10.1074/jbc.M006781200 (Pubitemid 32050297)
27. 7 responses. Journal of Leukocyte Biology 2009 85 6 978 986 2-s2.0-67149096558 10.1189/jlb.0408251
28. 7 knock-out mice. Journal of Biological Chemistry 2009 284 38 25813 25822 2-s2.0-70350012258 10.1074/jbc.M109.033134
29. 7 receptor-deficient mice are susceptible to bone cancer pain. Pain 2011 152 8 1766 1776 2-s2.0-79960453380 10.1016/j.pain.2011. 03.024
30. Beamer W. G., Donahue L. R., Rosen C. J., Baylink D. J., Genetic variability in adult bone density among inbred strains of mice. Bone 1996 18 5 397 403 2-s2.0-0029880186 10.1016/8756-3282(96)00047-6 (Pubitemid 26152301)
31. Furlan F., Galbiati C., Jorgensen N. R., Jensen J. E. B., Mrak E., Rubinacci A., Talotta F., Verde P., Blasi F., Urokinase plasminogen activator receptor affects bone homeostasis by regulating osteoblast and osteoclast function. Journal of Bone and Mineral Research 2007 22 9 1387 1396 2-s2.0-36049036935 10.1359/jbmr.070516 (Pubitemid 351339683)
32. Wu X., McKenna M. A., Feng X. U., Nagy T. R., McDonald J. M., Osteoclast apoptosis: the role of Fas in vivo and in vivo. Endocrinology 2003 144 12 5545 5555 2-s2.0-0344394236 10.1210/en.2003-0296 (Pubitemid 37476084)
33. 7 receptor inhibits formation of multinucleated human osteoclasts in vitro. Calcified Tissue International 2003 73 4 361 369 2-s2.0-0042047374 10.1007/s00223-002-2098-y (Pubitemid 37409423)
34. 7 receptors to activate NF- κ B in osteoclasts. Journal of Bone and Mineral Research 2004 19 4 642 651 2-s2.0-3242673859 10.1359/JBMR.040108 (Pubitemid 41071225)
35. 7 receptor-Pannexin1 complex: pharmacology and signaling. American Journal of Physiology, Cell Physiology 2008 295 3 C752 C760 2-s2.0-53449102024 10.1152/ajpcell.00228.2008
36. 7 receptor death complex. FEBS Letters 2007 581 3 483 488 2-s2.0-33846438625 10.1016/j.febslet.2006.12.056 (Pubitemid 46149626)
37. Brough D., Pelegrin P., Rothwell N. J., Pannexin-1-dependent caspase-1 activation and secretion of IL-1 β is regulated by zinc. European Journal of Immunology 2009 39 2 352 358 2-s2.0-60749110379 10.1002/eji.200838843
38. 7 receptor. EMBO Journal 2006 25 21 5071 5082 2-s2.0-33750473352 10.1038/sj.emboj.7601378 (Pubitemid 44658525)
39. Tatakis D. N., Interleukin-1 and bone metabolism: a review. Journal of Periodontology 1993 64 5, supplement 416 431 2-s2.0-0027218668 (Pubitemid 23208151)
40. Uy H. L., Dallas M., Calland J. W., Boyce B. F., Mundy G. R., Roodman G. D., Use of an in vivo model to determine the effects of interleukin-1 on cells at different stages in the osteoclast lineage. Journal of Bone and Mineral Research 1995 10 2 295 301 2-s2.0-0028928988
41. 7 receptors in NOD mouse pancreas during the development of diabetes. Autoimmunity 2007 40 2 108 116 2-s2.0-33947199802 10.1080/08916930601118841 (Pubitemid 46431568)
42. Riggs B. L., Khosla S., Melton L. J., Sex steroids and the construction and conservation of the adult skeleton. Endocrine Reviews 2002 23 3 279 302 2-s2.0-0035985305 10.1210/er.23.3.279 (Pubitemid 34651948)
43. Iwaniec U. T., Yuan D., Power R. A., Wronski T. J., Strain-dependent variations in the response of cancellous bone to ovariectomy in mice. Journal of Bone and Mineral Research 2006 21 7 1068 1074 2-s2.0-33745488185 10.1359/jbmr.060402 (Pubitemid 43962835)
44. Bouxsein M. L., Myers K. S., Shultz K. L., Donahue L. R., Rosen C. J., Beamer W. G., Ovariectomy-induced bone loss varies among inbred strains of mice. Journal of Bone and Mineral Research 2005 20 7 1085 1092 2-s2.0-20844432720 10.1359/JBMR.050307 (Pubitemid 40863796)